2024-11-18 03:46:26
Frost & Sullivan Publishes Q3-2018 Update Report on RedHill Biopharma Ltd.: RedHill published additional data from MAP US Phase III study of RHB-104 in Crohn's Disease; Steady-state sales in GI drugs; target price unchanged
Health/ 2023-07-22
Frost & Sullivan Publishes Q3-2018 U...

Equity Research is published in the framework of the Tel Aviv Stock Exchange (TASE) Analysis Program TEL AVIV,Israel,Nov. 26,2018--The TASE ...

MicuRx Enrolls First Patient in a Phase 2 Clinical Trial in U.S. for Novel Antibiotic, Contezolid Acefosamil
Health/ 2023-07-22
MicuRx Enrolls First Patient in a Phase ...

FOSTER CITY,Calif. and SHANGHAI,Nov.26,2018--MicuRx Pharmaceuticals,Inc.,today announced that the first patient has been enrolled in a Phase...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release